Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid Leukemia
Authors
- Ravi Bhatia (ORCID: https://orcid.org/0000-0001-5740-2316)
- Kimo Bachiashvili
- Omer Jamy (ORCID: https://orcid.org/0000-0003-2411-4742)
- Pankit J. Vachhani (ORCID: https://orcid.org/0000-0001-9779-6217)
- Kendall Diebold
- Razan Mohty (ORCID: https://orcid.org/0000-0002-0189-8233)
- Sravanti Rangaraju (ORCID: https://orcid.org/0000-0003-3545-0661)
- Manuel Ricardo Espinoza-Gutarra (ORCID: https://orcid.org/0000-0002-7906-8782)
- Devan Parker
- Sarah Worth (ORCID: https://orcid.org/0000-0002-6451-4890)
Institutions
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- eJHaem
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1002/jha2.70049
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00